[Other] Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial |
|
This post will be closed automatically in 2026-09-15 04:00
Best Answer
5 day(s) ago
|
| |
30
[Single chapter]Love between Desire and Will
20
Without Informed Consent: The Global Export of a Failed Paradigm of Care
20
Introduction to Renewable Energy
10
Management of Takayasu Arteritis – A 2026 Update
20
Molecular modeling of the carbohydrate corona formation on a polyvinyl chloride nanoparticle and its impact on the adhesion to lipid bilayers
